Condition

Sleep Apnea

Obstructive sleep apnea (OSA) is repeated upper-airway obstruction during sleep, leading to fragmented sleep and intermittent oxygen desaturation. It is closely associated with obesity and contributes to hypertension, insulin resistance, and cardiovascular risk.

Written by MagnaMetabolic Editorial Team Medically reviewed by Ariel Ortiz, MD — Bariatric & Metabolic Surgery Last reviewed: June 7, 2026

Common symptoms

  • Loud snoring.
  • Witnessed apneas or gasping.
  • Daytime sleepiness, morning headaches, brain fog.
  • Treatment-resistant hypertension.

Diagnosis

Diagnosis is typically based on in-laboratory polysomnography or validated home sleep apnea testing. Severity is graded by the apnea–hypopnea index (AHI).

Why it matters metabolically

OSA is associated with insulin resistance, glucose intolerance, hypertension, atrial fibrillation, and cardiovascular events. Effective treatment frequently improves blood pressure and quality of life.

Treatment

Continuous positive airway pressure (CPAP) is the most commonly used therapy. Weight loss, positional therapy, oral appliances, and surgical options are appropriate in selected patients.

Related reading

Book Consultation